|
Volumn 51, Issue 1315, 2009, Pages 50-52
|
Lacosamide for epilepsy
p a p p p p b c d e f g h i j k l a m n more.. |
Author keywords
[No Author keywords available]
|
Indexed keywords
CARBAMAZEPINE;
DEPAKOTE ER;
DEPAKOTE SPRINKLE;
DILANTIN INFATABS;
ETIRACETAM;
FELBAMATE;
GABAPENTIN;
HARKOSERIDE;
LAMOTRIGINE;
OMEPRAZOLE;
OXCARBAZEPINE;
PHENYTOIN;
PLACEBO;
PREGABALIN;
STAVZOR;
TOPIRAMATE;
UNCLASSIFIED DRUG;
VALPROATE SEMISODIUM;
VALPROIC ACID;
ZONISAMIDE;
ACETAMIDE DERIVATIVE;
ANTICONVULSIVE AGENT;
ABNORMAL VISION;
ATAXIA;
CLINICAL TRIAL;
DIPLOPIA;
DIZZINESS;
DRUG APPROVAL;
DRUG BIOAVAILABILITY;
DRUG ELIMINATION;
DRUG EXCRETION;
DRUG FORMULATION;
DRUG METABOLISM;
DRUG WITHDRAWAL;
EPILEPSY;
EUPHORIA;
FATIGUE;
FOCAL EPILEPSY;
HEADACHE;
HUMAN;
NAUSEA;
SHORT SURVEY;
SIDE EFFECT;
SOMNOLENCE;
TREATMENT RESPONSE;
TREMOR;
VOMITING;
ARTICLE;
RANDOMIZED CONTROLLED TRIAL;
UNITED STATES;
ACETAMIDES;
ANTICONVULSANTS;
DRUG APPROVAL;
EPILEPSIES, PARTIAL;
HUMANS;
RANDOMIZED CONTROLLED TRIALS AS TOPIC;
UNITED STATES;
|
EID: 67650340984
PISSN: 0025732X
EISSN: None
Source Type: Journal
DOI: None Document Type: Short Survey |
Times cited : (3)
|
References (6)
|